
Rhizome AI YC 申请
Rhizome AI 在 Winter 2026 批次的 Y Combinator 中作为一家 B2B 公司进行过。以下是:公司做什么、谁创立了它,以及其 YC 申请,按照真实 YC 表格逐题重建。
- YC 批次
- Winter 2026
- 行业
- B2B
- 团队规模
- 1
- 状态
- Active
- 已发布
- 2026
创始人
Chetan MishraFounder
Rhizome AI 做什么
It takes 500,000 days of office work to bring a drug to market. We want to make it 5. To get there, we need agents doing most of the work. Today, our research agent is the best way to know what the FDA thinks. Users ask a question and get an answer backed by up to 1,000 documents, where each statement has a citation. It’s the best because we have the best retrieval engine. We’ve tuned it on our life science-specific dataset, and we find what others miss. As more teams use Rhizome, we gain more data on what regulatory professionals actually need, which makes retrieval even better. This flywheel is how we become the retrieval engine that powers all human and agent work in life sciences. Chetan started his career as a research engineer, but quickly realized he enjoyed building more than research. He joined EvolutionaryScale as their sole founding product engineer, launching their developer-scientist platform and scaling to tens of thousands of users and billions of API calls. He was also #16 at Instabase helping banks with document processing, closing $7m as the technical closer. Agents can do magical things today, but most in life sciences only use them to edit emails. Agents are missing the context they need to 100x the number of drugs we can bring to market. Rhizome AI is focused on that critical problem.
Rhizome AI 的 YC 申请,重建版
Y Combinator 申请
Rhizome AI,Winter 2026 期。来自公开数据的真实申请问题解答。
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Rhizome AI
Agent Platform for Life Sciences
We built a research agent that helps regulatory professionals understand FDA guidance by answering their questions with citations from up to 1,000 relevant documents. It's powered by a retrieval engine tuned specifically on life science datasets that finds regulatory information others miss. Our product aims to automate much of the work involved in navigating drug approval processes.
I live in New York City and the company is based there and remotely distributed.
New York is a major life sciences hub, and remote lets us access talent and customers globally. This fits our need to stay close to regulatory experts and life sciences teams while keeping flexibility.
21 更多回答 在完整申请中
Founders, Progress, Idea, Equity, Curious, Batch Preference 包含在完整版中。创建免费账户即可在 YC Insights 中打开,紧邻每个其他 YC 批次。
常见问题解答
这是 Rhizome AI 的真实 YC 申请吗?
不是。Y Combinator 对提交的申请保密。这是重建版:使用 Rhizome AI 的公开数据(发布笔记、创始人背景、产品描述)回答真实的 YC 表格问题。它展示了像 Rhizome AI 这样的公司会如何向 YC 自我介绍,而不是他们提交的文本。
Rhizome AI 是哪个 YC 批次的?
Rhizome AI 是 Y Combinator Winter 2026 批次的成员。
谁创立了 Rhizome AI?
Rhizome AI 由 Chetan Mishra 创立。
Rhizome AI 做什么?
Agent Platform for Life Sciences
如何阅读完整的重建申请?
创建免费的 Round Funded 账户。YC Insights 中包含 Rhizome AI 的完整 26 个问题的版本,以及其他所有 YC 批次的公司信息。